Lazard Asset Management’s Adverum Biotechnologies ADVM Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-17
| Closed | – | – | 2281 |
|
|
2024
Q4 | $0 | Hold |
17
| – | – | ﹤0.01% | 2259 |
|
|
2024
Q3 | $0 | Sell |
17
-29
| -63% | – | ﹤0.01% | 2247 |
|
|
2024
Q2 | $0 | Sell |
46
-654
| -93% | – | ﹤0.01% | 2209 |
|
|
2024
Q1 | $9K | Sell |
700
-9,232
| -93% | -$119K | ﹤0.01% | 1872 |
|
|
2023
Q4 | $7K | Sell |
9,932
-557
| -5% | -$393 | ﹤0.01% | 2105 |
|
|
2023
Q3 | $15K | Buy |
10,489
+430
| +4% | +$615 | ﹤0.01% | 2126 |
|
|
2023
Q2 | $15K | Buy |
+10,059
| New | +$15K | ﹤0.01% | 2144 |
|
|
2021
Q2 | – | Sell |
-106
| Closed | -$1K | – | 1945 |
|
|
2021
Q1 | $1K | Hold |
106
| – | – | ﹤0.01% | 1820 |
|
|
2020
Q4 | $1K | Buy |
+106
| New | +$1K | ﹤0.01% | 1815 |
|
|
2015
Q1 | – | Sell |
-105
| Closed | -$5K | – | 1114 |
|
|
2014
Q4 | $5K | Buy |
+105
| New | +$5K | ﹤0.01% | 1099 |
|